Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in RA After Adalimumab Failure
NCT01927757Phase 4Terminated
- Sponsor
- Amgen
- Start
- May 2013
- Primary completion
- Jun 2015
- Modality
- Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 4 trial of etanercept in rheumatoid arthritis (RA), sponsored by Amgen. Started May 2013; status: terminated.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01927757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01927757.